Qingyong Li
- Molecular Biology top 10%
- Oncology top 10%
- Organic Chemistry top 10%
- Biomaterials top 5%
- Biomedical Engineering
- Topics
- Cancer therapeutics and mechanisms (30 papers)Drug Transport and Resistance Mechanisms (13 papers)Synthesis and biological activity (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qingyong Li
63 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 843
- Oncology 313
- Organic Chemistry 257
- Biomaterials 192
- Biomedical Engineering 167
Countries citing papers authored by Qingyong Li
This map shows the geographic impact of Qingyong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyong Li more than expected).
Fields of papers citing papers by Qingyong Li
This network shows the impact of papers produced by Qingyong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyong Li. The network helps show where Qingyong Li may publish in the future.
Co-authorship network of co-authors of Qingyong Li
This figure shows the co-authorship network connecting the top 25 collaborators of Qingyong Li. A scholar is included among the top collaborators of Qingyong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyong Li. Qingyong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 20 | |
| 6 | 6 | |
| 7 | 12 | |
| 8 | 10 | |
| 9 | 13 | |
| 10 | 76 | |
| 11 | 94 | |
| 12 | 18 | |
| 13 | 17 | |
| 14 | 3 | |
| 15 | 65 | |
| 16 | Research progress of bile acid as a drug carrier | 1 |
| 17 | 1 | |
| 18 | 8 | |
| 19 | 14 | |
| 20 | The seasonal dynamics of the content of syringin and total flavonoid in different parts of Acanthopanax senticosus | 2 |
About Qingyong Li
Qingyong Li is a scholar working on Toxicology, Molecular Medicine and Pharmaceutical Science, having authored 66 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (30 papers), Drug Transport and Resistance Mechanisms (13 papers) and Synthesis and biological activity (6 papers). The work is most often cited by research in Toxicology (100 citations), Molecular Medicine (122 citations) and Pharmacology (152 citations). Qingyong Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yuangang Zu, Liping Yao, Fengzhi Li, Xiang Ling, Jialin Xu, Tao Jiang, Wenchao Wang, Jiaoyan Ren, Yujuan Li and Xiaoyan Kang. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.